Cindy Crawford Simply Shared Her Nonsurgical Eyelid Raise Secret


We’re at all times all ears for a Cindy Crawford magnificence secret, and her newest one comes with a brand new partnership.

As introduced in the present day, the supermodel and entrepreneur is teaming up with Upneeq (oxymetazoline hydrochloride ophthalmic resolution, 0.1%), the primary and solely FDA-approved prescription eye drop for acquired ptosis, or low-lying eyelids. Used as soon as every day, it’s clinically confirmed to briefly carry the higher eyelids, making eyes seem extra open and awake in minutes. The outcomes last as long as eight hours, with zero downtime and no surgical procedure required.

Crawford isn’t simply the face of the marketing campaign; she’s additionally a longtime consumer. “Connection has at all times been about presence and confidence for me, and a lot of that’s communicated by the eyes,” she says. “Upneeq permits me to proceed to indicate up absolutely, simply as I’ve all through my profession.”

“This partnership represents a strong convergence, bringing collectively a real cultural icon like Cindy Crawford with Upneeq, a category-defining innovator in eye care,” says Upneeq CEO Lori Deo. “This marketing campaign celebrates presence and connection in on a regular basis moments, and Cindy has constructed a legacy of significant connection throughout generations. We’re thrilled to carry this defining partnership to life.”

The marketing campaign nods to Crawford’s iconic profession whereas celebrating girls of all ages, with creators, make-up artists and actual Upneeq customers sharing their very own tales about confidence and presence.

For anybody who has seen their eyelids feeling heavier or their eyes trying extra drained than they really feel, prescription-only Upneeq gives a compelling nonsurgical possibility, and it’s one which docs have backed since its FDA approval in 2020. As Boca Raton, FL oculoplastic surgeon Steven Fagien, MD, instructed us, using eyedrops to open up the eyes has been a trusted observe for years.

“It has been identified for years that sure topical ‘eyedrop’ chemical compounds trigger a constriction of an adjunct muscle of the higher eyelid that ‘opens the attention’ or lifts the higher eyelid,” he explains. “Consider it like Afrin Nasal Spray, which works within the nostril by an analogous impact of vasoconstriction. The thought is that a watch formulation with the identical compound, with a discount in focus to maximise results whereas decreasing uncomfortable side effects, will final a number of hours in most sufferers.”

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles